Bristol Myers (BMY)’ treatment of small cell lung cancer, atigotatug plus nivolumab fixed dose combination, received FDA ...

Panelists discuss treatment decision-making for metastatic non–-small cell lung cancer (NSCLC) with a ROS1 alteration, ...

In the continuing evolution of personalized medicine, a new study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with ...

Patients with lung adenocarcinoma typically carry a mutation in the Epidermal Growth Factor Receptor (EGFR) gene, making them ...

34,691 people played the daily Crossword recently. Can you solve it faster than others?34,691 people played the daily ...

It is Hawaii's largest robotic surgery centre for lung cancer treatment and will provide precision medicine tailored for each ...

During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, discussed trials of targeted agents for EGFR-mutant lung cancer.

The Cambridge-based company touted the data as evidence of the first successful use of CRISPR gene editing to fix a ...

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that ...

These tests help determine the stage of the cancer. Staging is important because lung cancer treatment is based on the stage of the cancer. Tests used to detect the spread of cancer may include ...

Scientists at the University of Virginia School of Medicine have uncovered a key reason why some people continue to ...

Throughout September, the FDA approved drugs for the treatment of diseases including lung cancer, multiple myeloma, thyroid cancer and breast cancer. Patients with stage 4 non-small cell lung cancer ...